Skip to main content
OpenTrials
Completed

NCT Number: NCT07176611

Guided Imagery in Perimenopausal Women

The study will be conducted in two groups as guided imagery and control. Participants will be approached at the Public Education Center. After perimenopausal women are evaluated according to eligibility criteria, those who are eligible will be informed about the research and written informed consent will be obtained from those who agree. Random assignment of women to the study groups will be carried out using randomization.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Akdağmadeni Public Education Center

Yozgat, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between 45-59 years of age
  • Being in the perimenopausal period according to the Stages of Reproductive Aging Workshop (STRAW) criteria (stage +1 or +2)
  • Early menopausal transition (STRAW -2): menstrual cycle length varies by 7 days or more
  • Late menopausal transition (STRAW -1): amenorrhea lasting 60 days or longer
  • Having entered natural menopause in postmenopausal women
  • Scoring above 10 on the Women's Health Initiative Insomnia Rating Scale
  • Owning a smartphone
  • Ability to understand and speak Turkish
  • No hearing impairment
  • Volunteering to participate in the study

Exclusion criteria

  • Having received or currently receiving hormone replacement therapy
  • Alcohol use
  • Practicing another mind-body intervention
  • Having a diagnosed disease that may cause sleep disorders and receiving medical treatment
  • Having a diagnosed disease that may significantly affect quality of life and receiving medical treatment

Treatment and study plan

guided imagery

Other

Participants in this group will receive the guided imagery intervention. The guided imagery audio recording will be applied in a quiet room once during the initial session, and participants will be instructed to continue the practice at home before sleep for eight weeks.

Primary outcomes

  1. Change in Quality of Life

    Time frame: at the beginning of the study, 4 weeks and 8 weeks later

    The Menopause-Specific Quality of Life Questionnaire-II (MENQOL-II) is a 29-item Likert-type scale used to assess the presence and severity of menopausal symptoms in women aged 45-59, including premenopausal, perimenopausal, postmenopausal, and surgical menopause. The scale has four subdomains: vasomotor, psychosocial, physical, and sexual. Each item is scored from 1 to 8, yielding a total score range between 29 and 232. Higher scores indicate a greater negative impact of menopausal symptoms on quality of life.

  2. Change in Insomnia

    Time frame: at the beginning of the study, 4 weeks and 8 weeks later

    The Women's Health Initiative Insomnia Rating Scale (WHIIRS) is a 5-item Likert-type scale used to evaluate insomnia symptoms, including sleep onset, sleep maintenance, early awakening, and sleep quality. Each item is scored between 0 and 4, with a total score ranging from 0 to 20. Higher scores indicate greater severity of insomnia

Sponsors and collaborators

Lead sponsor

Menekşe Nazlı AKER

Other

Registry information

Official study title

The Effect of Guided Imagery on Quality of Life and Insomnia in Perimenopausal Women

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 16, 2025
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.